Need help paying for IDELVION?

Get co-pay support

We understand managing your condition in a cost-effective manner can be challenging, which is why we created the My Access® co-pay program for IDELVION. This program may cover up to $12,000 of annual out-of-pocket expenses associated with your IDELVION therapy. If you have US-based private commercial insurance that covers therapy, you may be eligible.

How do I get started?

It's simple. Begin by calling 1-800-676-4266 to speak with an IDELVION My SourceSM Care Coordinator and ask about the My Access® co-pay program. We'll help you figure out the next steps. Or, to get started right away, print and fill out the enrollment form below. Follow the instructions on it, and we'll contact you.

Print the enrollment form

What do I get?

If eligible, you may receive up to $12,000 a year toward out-of-pocket expenses associated with IDELVION therapy.* You'll also be re-enrolled in the program annually.

What does this cover?

This program covers only the costs directly associated with the purchase of IDELVION. Services such as nursing and infusion services are not covered under this program.

Where can I purchase IDELVION under this program?

IDELVION must be purchased from eligible sites, such as specialty pharmacies, hemophilia treatment centers, and outpatient hospital services.

Am I eligible?

The IDELVION My Access program is available to US residents with a private commercial insurance plan (US-based). Those covered by state- or federally funded programs are not eligible; these programs include, but are not limited to, Medicare, Medicaid, PCIP, Champus, Tricare, veterans health insurance, and any other state- or federally funded program.

Since the IDELVION My Access program only covers medication and not medical services, there should be no state-specific restrictions to your eligibility.

I'm a caregiver. Is my child eligible?

Yes. Both adults and children can enroll in the IDELVION My Access program.

I have more questions. What can I do?

Call 1-800-676-4266 to speak with an IDELVION MySourceSM Care Coordinator right away. We can answer any other questions you may have about the My Access program.

*Terms and conditions apply.

Zero bleeds

IDELVION delivers a median annualized spontaneous bleeding rate of zero in clinical trials†

See IDELVION powerful protection
Sign up for IDELVION icon

Is it time for a Factor IX switch? Get the information you need

Sign up here

Zero median annualized spontaneous bleeding rate when dosed at 7 or 14 days in clinical trials.

You are now leaving the current website.

Do you want to continue?

No Yes